Adipose-Derived Stem Cells and Tacrolimus Improve Nerve Regeneration in a Rat Sciatic Nerve Defect Model
Authors:
- Georgios N. PanagopoulosGPGeorgios N. Panagopoulos
- Panayiotis D. MegaloikonomosPMPanayiotis D. Megaloikonomos
- Evanthia A. MitsiokapaEMEvanthia A. Mitsiokapa
- Myrto BamiMBMyrto Bami
- Georgios AgrogiannisGAGeorgios Agrogiannis
- Elizabeth O. JohnsonEJElizabeth O. Johnson
- Panayotis N. SoucacosPSPanayotis N. Soucacos
- Panayiotis J. PapagelopoulosPPPanayiotis J. Papagelopoulos
- Andreas F. MavrogenisAndreas F. Mavrogenis
- 1 November 2023
- journal article
- research article
- Published by SLACK, Inc. in Orthopedics
- Vol. 46 (6) , E353-E361
Abstract
This study compared the effect of undifferentiated adipose-derived stem cells (ADSCs) vs tacrolimus (FK506) in peripheral nerve regeneration in a rat sciatic nerve complete transection model. Forty Wistar rats were equally distributed in four groups. In the SHAM surgery group, the sciatic nerve was exposed and no further intervention was done. In the conduit-alone group (the SLN group), a 10-mm nerve gap was created and bridged with a fibrin conduit filled in with normal saline. In the FK506 group, the fibrin conduit was injected with soluble FK506. In the ADSC group, the conduit was impregnated with undifferentiated ADSCs. Nerve regeneration was assessed by means of walking track analysis, electromyography, and neurohistomorphometry. Clinically and microscopically, nerve regeneration was achieved in all groups at 12 weeks. Walking track analysis confirmed functional recovery in the FK506 and ADSC groups, but there was no difference between them. Recovery in function was also achieved in the SLN group, but it was inferior (P<.05). Electromyography demonstrated superior nerve regeneration in the FK506 and ADSC groups compared with the SLN group (P<.05), with no difference between the FK506 and ADSC groups. Similarly, histology showed no difference between the FK506 and ADSC groups, although both outperformed the SLN group (P<.05). No complications were observed. Successful peripheral nerve regeneration can be accomplished after a 10-mm nerve defect treated with nerve conduits. Superior nerve regeneration may be expected when the conduits are loaded with undifferentiated ADSCs or FK506, with similar outcomes for ADSCs and FK506. [Orthopedics. 202x;4x(x):xx-xx.].Keywords
This publication has 64 references indexed in Scilit:
- Effect of FK506 in reducing scar formation by inducing fibroblast apoptosis after sciatic nerve injury in ratsCell Death & Disease, 2013
- Neural regeneration in a novel nerve conduit across a large gap of the transected sciatic nerve in rats with low‐level laser phototherapyJournal of Biomedical Materials Research Part A, 2013
- A Systematic Review on the Use of Fibrin Glue for Peripheral Nerve RepairPlastic and Reconstructive Surgery, 2011
- Tacrolimus (FK506): Safety and Applications in Reconstructive SurgeryHAND, 2009
- The Incidence of Peripheral Nerve Injury in Extremity TraumaAmerican Journal of Physical Medicine & Rehabilitation, 2008
- Bimodal dose‐dependence of FK506 on the rate of axonal regeneration in mouse peripheral nerveMuscle & Nerve, 2002
- Functional Evaluation of Gap Vs. Abutment Repair of Peripheral Nerves in the RatJournal of Reconstructive Microsurgery, 1996
- Bioartificial Nerve Grafts:A prototypeScandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery, 1996
- Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexesCell, 1991
- Axonally transported proteins associated with axon growth in rabbit central and peripheral nervous systemsJournal of Cell Biology, 1981